Synapse - David Straus

Results (356)

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

Journal Article

Straus, D. J.; Portlock, C. S.; Qin, J.; Myers, J.; Zelenetz, A. D.; Moskowitz, C.; Noy, A.; Goy, A.; Yahalom, J.
Blood (2004)

Fulltext@MSK | Save

Hodgkin's disease

Book Section

Yahalom, J.; Straus, D.
In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 7th ed (2003)

Fulltext@MSK | Save

Phase II clinical experience with the novel proteasome inhibitor bortezomib (formerly PS-341) in patients with indolent and mantle cell lymphomas

Meeting Abstract

O'Connor, O. A.; Wright, J.; Moskowitz, C.; Straus, D.; Macgregor-Cortelli, B.; Muzzy, J.; Choi, P.; Schenkein, D.; Zelenetz, A. D.
EJC Supplements (2003)

Fulltext@MSK | Save

Stanford V and radiotherapy for advanced and locally extensive Hodgkin's disease (HD): The memorial Sloan-Kettering Cancer Center (MSKCQ) experience

Meeting Abstract

Yahalom, J.; Edwards-Bennett, S.; Jacobs, J.; Moskowitz, C. H.; Wu, E. J.; Cotler, M.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Portlock, C. S.; more...
Blood (2003)

Fulltext@MSK | Save

Early treatment with epoetin alfa improves anemia, quality of life (QOL), and productivity in patients (Pts) with hematologic malignancies and mild anemia during chemotherapy (CT)

Meeting Abstract

Straus, D. J.; Testa, M.; Riggs, S. A.; Tulpule, A.; Sarokhan, B.
Blood (2003)

Fulltext@MSK | Save

Promising activity of the proteasome inhibitor bortezomib (velcade) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma

Meeting Abstract

O'connor, O.; Wright, J.; Moskowitz, C. H.; Muzzy, J.; Macgregor-Cortelli, B.; Hamlin, P.; Straus, D.; Trehu, E.; Schenkein, D. P.; Zelenetz, A. D.
Blood (2003)

Fulltext@MSK | Save

Risk-adpated high dose chemoradiotherapy and ASCT for patients with relapsed and primary refractory Hodgkin's disease: An intent to treat analysis

Meeting Abstract

Moskowitz, C. H.; Kewalramani, T.; Nimer, S. D.; Rice, R. D.; Rosenzweig, L.; Horwitz, S.; Noy, A.; O'connor, O.; Portlock, C. S.; Straus, D.; more...
Blood (2003)

Fulltext@MSK | Save

Gallium nitrate in the treatment of lymphoma

Journal Article

Straus, D. J.
Seminars in Oncology (2003)

Fulltext@MSK | Save

Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma